Overview
This annual one-day meeting is an exciting program that will highlight world-class faculty discussing up-to-date information about drugs and technologies that are indicated in a variety of common cardiovascular diseases. The content will be oriented toward the entire cardiac care team. The educational objectives of the session will address the skills required of cardiovascular professionals for providing evidence based care to patients with cardiovascular disease. The intimate format of this meeting will allow the audience to interact with invited speakers, network with colleagues from across the state and meet the cardiology fellows-in-training within the state.

Learning Objectives

1. Review features, current guidelines on management and invasive and novel pharmacotherapies for HCM.

2. Discuss newer tools including strain, pressure-volume loops, myocardial work, dyssynchrony, and diastology for assessing ventricular performance of adult congenital heart disease.
   
3. Recognize when to refer patients with suspected genetic cardiovascular diseases for genetic counseling and testing and how to interpret actionable results.
4. Explore the burden and identify targets to address health disparities in cardiovascular disease.
5. Discuss the types, diagnostic approach, current FDA therapies and ongoing clinical trials in amyloidosis.
6. Discuss the current definitions and evidence behind the new definitions of cardiogenic shock.
7. Review the different presentation, diagnosis, treatment and outcomes of Peripheral Artery Disease in women.
8. Review the input from non-gated chest CT, coronary CT and FFR in multiple cardio-oncology settings.

Schedule of Events & Speakers

7:00 am	Registration, Breakfast, Visit with Exhibitors
7:55 am	Opening Remarks & Housekeeping C.A. Sivaram, MD, FACC Moderator
8:00 am	Contemporary Management of HCM: From Drugs to Septal Reduction Therapy and Back Again Srihari Naidu, MD, FACC
8:30 am	New Ways of Assessing Ventricular Function in Adults with Congenital Heart Disease Shelby Kutty, MD, FACC
9:00 am	Is It All in The Genes? Incorporating Cardiovascular Genetics into Your Practice Nosheen Reza, MD, FACC
9:30 am	Refreshment Break and Visit with Exhibitors
10:00 am	Health Care Disparities in Cardiovascular Disease: What is Known & Opportunities Quentin Youmans, MD
10:30 am	Keynote Address: ACC Presidential Team Leader Christopher Kramer, MD FACC
11:20 am	Cardiac Amyloidosis - A Review on Contemporary Diagnostic & Management Strategies Marcus Anthony Urey, MD
11:50 am	Lunch & Oklahoma ACC Governor Report Eugen Ivan, MD, FACC
12:10 pm	Current Definitions of Cardiogenic Shock Mohit Pahuja, MD
12:30 pm	Sex Differences & Sex-Related Disparities in Peripheral Artery Disease (PAD) Razan Elsayed, MD
12:45 pm	Use of Computed Tomography Imaging in Cardio-Oncology: Contemporary Practices & Emerging Applications Mohamad Khattab, DO
1:00 pm	Conclusion & Prizes C.A. Sivaram, MD, FACC

Target Audience
Adult Cardiologists, Pediatric Cardiologists, Cardiothoracic Surgeons, Cardiology Fellows-in-Training, the entire Cardiac Care Team, including but not limited to: Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Pharmacists.

Registration
$50 ACC Physician Members
$25 ACC CCA Members
$150 Non ACC Physician Members
$75 Non ACC CCA Members
$0 Fellow in Training
Course fee includes CME credits and meals.

Cancellations must be received in writing by February 17, 2024 in order to receive a full refund. No refunds will be issued after February 17, 2024.

Register online now!

Accreditation
The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

When
Saturday, March 2, 2024
7:00 AM - 1:15 PM

Where
Nicholson Auditorium
1000 N.E. 13st Street
Oklahoma City, OK 73104
On the University of Oklahoma Health Sciences Campus.

Download the full brochure.

Interested in exhibiting at the Annual Scientific Meeting? Download the Exhibitor Prospectus.